Diclofenac Sodium And Misoprostol Tablet, Delayed Release
Product Images NDC 68001-231

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium And Misoprostol (NDC 68001-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Label for Diclofenac Sodium and Misoprostol delayed-release tablets, USP, 50 mg/0.2 mg strength. The label shows each tablet contains 50 mg diclofenac sodium USP and 0.2 mg misoprostol USP. It states Rx only and includes pharmacy dispensing instructions and contraindication warnings. The package contains 60 tablets and is labeled by BluePoint Laboratories.*

FDA Label Image

Image 2

Label for Diclofenac Sodium and Misoprostol delayed-release tablets, USP, strength 75 mg/0.2 mg. The label states each tablet contains 75 mg diclofenac sodium (69.58 mg diclofenac) and 0.2 mg misoprostol. It indicates prescription use (Rx only), a package size of 60 tablets, and directions to dispense the medication guide. Manufactured by Teva Pharmaceuticals USA for BluePoint Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.